Palisade Bio, Inc. (PALI) DCF Valuation

Palisade Bio, Inc. (PALI) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Palisade Bio, Inc. (PALI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Palisade Bio, Inc.? Our (PALI) DCF Calculator integrates real-world data with extensive customization features, enabling you to adjust forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .3 .2 .1 .1 .1 .0
Revenue Growth, % 0 -12.17 -100 0 0 -28.04 -28.04 -28.04 -28.04 -28.04
EBITDA -8.2 -9.9 -24.1 -15.3 -12.3 .0 .0 .0 .0 .0
EBITDA, % -53260.21 -73528.11 100 100 -4912.4 -20 -20 -20 -20 -20
Depreciation .1 .1 .2 .2 .0 .1 .1 .1 .1 .0
Depreciation, % 934.51 1079.88 100 100 1.6 80.32 80.32 80.32 80.32 80.32
EBIT -8.3 -10.1 -24.2 -15.5 -12.3 .0 .0 .0 .0 .0
EBIT, % -54194.72 -74607.99 100 100 -4914 -20 -20 -20 -20 -20
Total Cash 5.1 .7 10.5 12.4 12.4 .2 .1 .1 .1 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .1 .2 1.4 .1
Account Receivables, % 136.83 436.39 100 100 59.2
Inventories .0 -2.2 -.2 -1.4 .0 .0 .0 .0 .0 .0
Inventories, % 0 -16475.98 100 100 0 20 20 20 20 20
Accounts Payable .8 2.5 1.3 1.8 .7 .2 .1 .1 .1 .0
Accounts Payable, % 5355.37 18764.79 100 100 279.2 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 -44.38 100 100 -1.6 -9.2 -9.2 -9.2 -9.2 -9.2
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.3 -10.3 -24.8 -13.9 -12.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.4 -6.3 -28.0 -13.3 -13.5 -.5 .1 .1 .0 .0
WACC, % 8.68 8.68 8.68 8.53 8.68 8.65 8.65 8.65 8.65 8.65
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -12
Equity Value 12
Diluted Shares Outstanding, MM 0
Equity Value Per Share 26.41

What You Will Get

  • Real PALI Financials: Includes historical and forecasted data for precise valuation.
  • Adjustable Inputs: Customize WACC, tax rates, revenue growth, and capital expenditures.
  • Automatic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Palisade Bio's future performance.
  • Clear and Intuitive Design: Designed for professionals, yet user-friendly for newcomers.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future financial forecasts for Palisade Bio, Inc. (PALI).
  • Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
  • Interactive Dashboard: Utilize clear charts and summaries to effectively visualize your valuation insights.
  • Designed for All Skill Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Palisade Bio data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Palisade Bio’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Palisade Bio, Inc. (PALI)?

  • Accurate Data: Up-to-date Palisade Bio financials provide dependable valuation outcomes.
  • Customizable: Tailor essential metrics such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations save you from starting from scratch.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants focusing on biotech.
  • User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Individual Investors: Gain insights to make informed decisions about investing in Palisade Bio, Inc. (PALI).
  • Financial Analysts: Enhance valuation assessments with comprehensive financial models tailored for Palisade Bio, Inc. (PALI).
  • Consultants: Provide clients with accurate and timely valuation analyses for Palisade Bio, Inc. (PALI).
  • Business Owners: Learn about the valuation of biotech firms like Palisade Bio, Inc. (PALI) to inform your own business strategies.
  • Finance Students: Explore valuation methodologies using real data and case studies from Palisade Bio, Inc. (PALI).

What the Template Contains

  • Historical Data: Includes Palisade Bio’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Palisade Bio’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Palisade Bio’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.